Concordia International is part of the Concordia International Corp, a specialty pharmaceutical company focused on becoming a leader in European specialty, off-patent medicines [please see our Corporate website here
]. We have a strong international footprint and supply a diversified portfolio of more than 200 well-established off-patent molecules to patients, partners and healthcare authorities in more than 90 countries [see our Medicines here
]. We have an extensive Environmental, Social & Governance programme [see here
"Concordia International is part of the Concordia International Corp, a diverse international company focused on legacy pharmaceutical products and orphan drugs. We have a number of product ranges, including Concordia products, Amdipharm products, Mercury Pharma products, Abcur products, BnM products and Focus Pharma products. For more information please visit our Products page."